Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders' Equity

v3.25.4
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2022   78,745      
Balance at beginning of period at Dec. 31, 2022 $ 676,385 $ 8 $ 722,778 $ (1,021) $ (45,380)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   2,841      
Common stock issued pursuant to equity awards, net 26,237   26,237    
Employee stock purchase plan (in shares)   232      
Employee stock purchase plan 4,379   4,379    
Stock-based compensation 55,181   55,181    
Other comprehensive income (loss) (2,770)     (2,770)  
Net loss (73,147)       (73,147)
Balance at end of period (in shares) at Dec. 31, 2023   81,818      
Balance at end of period at Dec. 31, 2023 686,265 $ 8 808,575 (3,791) (118,527)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   2,502      
Common stock issued pursuant to equity awards, net 8,175   8,175    
Employee stock purchase plan (in shares)   293      
Employee stock purchase plan 4,102   4,102    
Stock-based compensation 65,971   65,971    
Other comprehensive income (loss) (3,032)     (3,032)  
Net loss $ (245,198)       (245,198)
Balance at end of period (in shares) at Dec. 31, 2024 84,613 84,613      
Balance at end of period at Dec. 31, 2024 $ 516,283 $ 8 886,823 (6,823) (363,725)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   2,651      
Common stock issued pursuant to equity awards, net 3,694 $ 1 3,693    
Repurchase of common stock (in shares)   (1,144)      
Repurchase of common stock (20,000)   (20,000)    
Employee stock purchase plan (in shares)   331      
Employee stock purchase plan 3,568   3,568    
Stock-based compensation 77,178   77,178    
Other comprehensive income (loss) 7,853     7,853  
Net loss $ (136,681)       (136,681)
Balance at end of period (in shares) at Dec. 31, 2025 86,451 86,451      
Balance at end of period at Dec. 31, 2025 $ 451,895 $ 9 $ 951,262 $ 1,030 $ (500,406)